BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Insulet Corp. (“Insulet” or the “Company”) (NASDAQ: PODD) concerning the recent disclosures regarding its lackluster earnings, and the Company’s and its officers’ possible violations of federal securities laws. The Law Offices of Howard G. Smith is preparing a complaint to recover damages on behalf of Insulet investors.
Insulet, the maker of insulin infusion systems, posted results on April 30, 2015, after the market close, that fell below analyst expectations. The Company posted quarterly revenue of $61.2 million in the period, which did not meet an analysts survey expecting $68.3 million. For the current quarter ending in June, Insulet said it expects revenue in the range of $67 million to $70 million. Insulet also provided full-year revenue projections in the range of $305 million to $320 million.
On this news Insulet shares fell nearly 12%, or $3.33 per share during intra-day trading on May 1, 2015, on unusually heavy volume.
If you purchased shares of Insulet between February 2013 through April 30, 2015, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.